COMMUNIQUÉS West-GlobeNewswire

The International Myeloma Foundation Wants You to #KnowMyeloma for Blood Cancer Awareness Month 2026
27/08/2026
STUDIO CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Designated in 2010 by U.S. Congress, September Blood Cancer Awareness Month aims to create awareness, increase fundraising, and support patients affected by all [...]
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors
27/08/2026
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc., today announced the appointments of John C. Jacobs and Scott Robertson to its Board of Directors. Mr. Jacobs is a seasoned industry leader with [...]
ICU Medical to Participate in Upcoming Investor Conferences
27/08/2026
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the [...]
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
27/08/2026
NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
27/08/2026
Differentiated Profile versus RAS-Targeted Approaches Including Revolution Medicines’ Daraxonrasib MELBOURNE, Australia, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “ [...]
Biomerica Announces $2.23 Million Financing
27/08/2026
Financing priced at $1.60 with no warrants or discount B. Riley Principal Capital and B. Riley executives, as well as Biomerica's CEO and all members of Biomerica’s Board of Directors participated in the financing [...]
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
27/08/2026
PLYMOUTH MEETING, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2026 Cantor Global [...]
Orion Corporation to commence acquisition of own shares for its share-based incentive plans
27/08/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 AUGUST 2026 at 13.00 EEST Orion Corporation to commence acquisition of own shares for its share-based [...]
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
27/08/2026
Paris, France - August 27, 2026 – HighLife SAS, a medical technology company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral [...]
Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU
27/08/2026
Combines Osivax's proprietary OVX836 T-cell vaccine and technology with GC Biopharma's marketed influenza vaccine and worldwide manufacturing expertise Positions Osivax as the global development lead for a [...]
hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets
27/08/2026
London, UK – 27 August 2026 , hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces the acquisition of CRS Clinical [...]
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
27/08/2026
MELBOURNE, Australia and NEW YORK, Aug. 27, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced its tenth consecutive annual profit and further rise in free cash in the [...]
Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma
27/08/2026
Press Release Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma FDA sets Prescription Drug User Fee Act (PDUFA) review response date by 30 April 2027 Two NDAs filed in major markets, with commercial partners [...]
Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome
27/08/2026
Communiqué de presse Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome La FDA a fixé la date de réponse à l’examen de la NDA dans le cadre du Prescription Drug User Fee Act (PDUFA) au [...]
IBA reports Half Year 2026 results, on track with its improved profitability trajectory
27/08/2026
Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance and continued [...]
IBA publie ses résultats semestriels 2026, et confirme sa trajectoire d’amélioration de la rentabilité
27/08/2026
Louvain-La-Neuve, Belgique, 27 août 2026, 7h00 - IBA (Ion Beam Applications S.A.), annonce aujourd’hui ses résultats consolidés pour le premier semestre 2026, avec une performance conforme aux prévisions pour l’exercice [...]
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates
27/08/2026
SHANGHAI, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Mesoblast Reports Substantial Revenue Growth to US$120M
27/08/2026
RYONCIL Market Share Expands; Phase 3 Back Pain Trial Completes Treatment Financial Results and Operational Update for Full Year Ended June 30, 2026 NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: [...]
Onco360® Has Been Selected as a National Pharmacy Partner for RASONQUE™ (daraxonrasib)
27/08/2026
LOUISVILLE, Ky., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, is grateful to be selected as a pharmacy partner by Revolution Medicines for RASONQUE™ (daraxonrasib), [...]

Pages